ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 633

Immunological and Clinical Relationships of Synovial IL-17+ T Cells in Psoriatic Arthritis

Bruce Kirkham1, Bina Menon2 and Leonie S. Taams3, 1Rheumatology, Guy's & St Thomas NHS Foundation Trust, London, United Kingdom, 2Rheumatology, Guy's and St. Thomas' Foundation Hospital NHS Trust, London, United Kingdom, 3Centre for Molecular and Cellular Biology of Inflammation, King's College London, London, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: CD8 cells, cytokines and psoriatic arthritis, Synovial Immune Biology

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose

We recently reported elevated numbers of synovial fluid IL-17+CD4- T cells (mainly CD8+ (Tc17) cells) in Psoriatic Arthritis (PsA), correlating with clinical, serological and imaging measures of disease activity (1).  These relationships are not found with CD4+ IL-17+ (Th17) synovial cells.  Here we report the relationship of synovial fluid T cell cytokine expression with PsA clinical patterns, and the relationships between synovial fluid cytokine-expressing T cells.

Methods

Mononuclear cells from synovial fluid (SF) and peripheral blood (PB) samples from 22 patients with PsA were isolated and stimulated for three hours in vitro with PMA and ionomycin in the presence of GolgiStop. CD3+ T cells were investigated for cytokine expression (IL-17A, IFN-γ, TNF-α, IL-22, IL-21, IL-10) by flow cytometry. Clinical measures and Power Doppler Ultrasound (PDUS) of the affected joint were made at the time of joint aspiration.

Results

Of 22 subjects, 16 (73%) had an oligoarthritis (<5 involved joints) and 6 (27%) a polyarticular pattern of PsA, with 9 (41%) having co-existing axial disease.  2 subjects had a history of dactylitis, 8 of enthesitis and 5 of nail disease.

All clinical subgroup patients had elevated synovial IL-17+CD4- and IL-17+CD4+ T cells compared to PB, which was significant in the oligo (p=0.001 and p=0.02 respectively) and axial groups (p=0.01 for both), with the polyarthritis group increase not statistically significant (p=0.06 for both), most likely due to low numbers. 

TNF-α+CD4- T-cell frequency positively correlated with DAS28 (r=0.51, p=0.02) with a trend for TNF-α+CD4+ T-cells and DAS28 (r=0.43, p=0.07).  In contrast to IL-17+CD4- T cells, there was no correlation between TNF-α+ T-cells and ESR, CRP or PDUS. IL-22+CD4- cells correlated with PDUS. No other T cell cytokine expression pattern correlated with clinical measures.

Relationships of cytokine expressing T cells were assessed for the percentages of IL-17+CD4- T cells and IFN-γ+, TNF-α+, IL-22+, IL-21+ and IL-10+ CD4- T-cells in PsA SF.  Only TNF-α+ cells positively correlated with IL-17+ cells in the CD4- T-cell compartment (r=0.55, p=0.01).  This relationship may be partly explained by the finding that 60% of IL-17+CD4- cells co-express TNF-α. IL-22 was co-expressed in 22% of IL-17+ CD4- T cells.

Conclusion

These data suggest that IL-17 expressing CD4- (CD8+) T cells are found in all articular patterns of PsA.  The correlation of IL-17+ and TNF-α+ CD4- cells suggests that IL-17 and TNF-α may be related in expression as well as synergy of function.

Ref 1. Menon B,et al.Arthritis Rheumatol. 2014;66:1272-81.


Disclosure:

B. Kirkham,
None;

B. Menon,
None;

L. S. Taams,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immunological-and-clinical-relationships-of-synovial-il-17-t-cells-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology